Syndicated on Yahoo Finance, this story covers Sigrid securing US market access for its patented SiPore® technology after the SHINE study, the largest study of its kind in prediabetes.
Media Coverage
Sigrid Therapeutics Secures U.S. Market Access for SiPore® Technology
Media: Yahoo Finance
Yahoo Finance carries the news that Sigrid has secured US market access for SiPore® following the SHINE prediabetes study.
US market accessSHINE trial


